Using immunoblot analysis, we demonstrated overexpression of the CLDN-3 and -4 integral membrane proteins in 4 of 9 and 5 of 9 endometrial cancer cell lines, respectively. This evidence concerns the gene CLDN3 and endometrial cancer.